Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer

Anxin Gu1, Yamin Jie2, Qiang Yao1

  • 11 Department of Radiotherapy, the Third Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Insights

Slug promotes ovarian cancer metastasis and angiogenesis. Inhibiting slug significantly reduces tumor growth, invasion, and blood vessel formation, offering a potential therapeutic target for this lethal gynecologic malignancy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gynecologic Oncology

Background:

  • Ovarian cancer is a leading cause of cancer death in women, often involving epithelial cell transformation.
  • Tumor progression includes epithelial-mesenchymal transition (EMT), invasion, migration, and angiogenesis.
  • Slug is implicated in cancer cell motility and invasion via EMT.

Purpose of the Study:

  • To investigate the role of Slug in ovarian cancer invasion and angiogenesis.
  • To determine the correlation between Slug expression and clinical parameters.
  • To evaluate Slug's impact on tumor growth and metastasis in vivo.

Main Methods:

  • Analysis of Slug expression in patient tumors.
  • Transwell migration assays to assess invasion and migration.
  • In vitro endothelial cell assays for angiogenesis.
  • Xenograft mouse models to study tumor growth and angiogenesis in vivo.
  • Short hairpin RNA (shRNA) to inhibit Slug expression.

Main Results:

  • High Slug expression correlates with higher tumor grade, lymph node metastasis, and poorer prognosis.
  • Slug knockdown reduces ovarian cancer cell invasion, migration, and angiogenesis.
  • Inhibition of Slug decreases tumor growth and microvessel density (MVD) in vivo.
  • Slug knockdown suppresses angiogenesis via the ccn1/vascular endothelial growth factor pathway.

Conclusions:

  • Slug is significantly associated with tumor metastasis and angiogenesis in ovarian cancer.
  • Targeting Slug may represent a promising therapeutic strategy for ovarian cancer.
  • Slug's role in promoting angiogenesis via ccn1/VEGF warrants further investigation.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K